University Hospital for Tumours of Zagreb: Difference between revisions

From Beacon
 
(64 intermediate revisions by 4 users not shown)
Line 1: Line 1:
<span style="display:none">forresearchers</span>
<span style="display:none">forpatients</span>
<span style="display:none">forproviders</span>
<span style="display:none">forpolicymakers</span>
<span style="display:none">croatiacountry</span>
<span style="display:none">hospital</span>
<span style="display:none">isCancerCenter</span>
[https://wiki.beaconcancer.org/index.php?title=Cancer_Centers Go back to Cancer Centers list.]
[https://wiki.beaconcancer.org/index.php?title=Cancer_Centers Go back to Cancer Centers list.]
 
{{#set:
[[Croatia|See other cancer centers in Croatia.]]
[[hasCoordinates::45.813039, 15.9433842]]  
 
}}
== Trials ==
== [[hasClinicalTrial::University Hospital for Tumours of Zagreb Trials|Trials]] ==
<div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide">
<div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide">
'''[https://wiki.beaconcancer.org/index.php?title=A_Study_Investigating_the_Outcomes_and_Safety_of_Atezolizumab_Under_Real-World_Conditions_in_Patients_Treated_in_Routine_Clinical_Practice_(IMreal)_(University_Hospital_for_Tumors_of_Zagreb) A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice (IMreal)]'''
[https://clinicaltrials.gov/ct2/show/NCT03782207?recrs=abdfm&cond=Cancer&locn=Clinical+Hospital+Center+Sestre+Milosrdnice%3B+Clinic+for+tumors&cntry=HR&draw=2&rank=2]
'''Summary:''' This is a non-interventional, multi-country, multi-centre, multiple cohort prospective study, with retrospective collection of prior medical/treatment history data from medical records, designed to assess the real-world outcomes and safety of atezolizumab for indications in the existing label in the real world setting of routine clinical practice.
'''Sponsor, manager, or home institution:''' Hoffmann-La Roche
'''Intervention/Treatment:''' Drug: Atezolizumab
'''Number of patients:''' 3400 participants
'''Beginning Date:''' December 20, 2018
'''Last Update:''' December 20, 2022
'''Recruitment Status:''' Recruiting.
'''Cancer areas of interest:''' Urothelial Carcinoma, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Hepatocellular Carcinoma.
'''[https://wiki.beaconcancer.org/index.php?title=A_Study_of_Trastuzumab_Emtansine_in_Combination_With_Atezolizumab_or_Placebo_as_a_Treatment_for_Participants_With_Human_Epidermal_Growth_Factor_2_(University_Hospital_for_Tumors_of_Zagreb) A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2]'''
[https://clinicaltrials.gov/ct2/show/NCT04740918?recrs=abdfm&cond=Cancer&locn=University+Hospital+for+Tumors&cntry=HR&draw=1&rank=2]
'''Summary:''' This study will evaluate the efficacy, safety and patient-reported outcomes of trastuzumab emtansine plus atezolizumab compared with trastuzumab emtansine plus placebo in participants with HER2-positive and PD-L1-positive LABC or MBC.Participants must have progressed either during or after prior trastuzumab- (+/- pertuzumab) and taxane-based therapy for LABC/MBC; or during (or within 6 months after completing) trastuzumab- (+/-pertuzumab) and taxane-based therapy in the neoadjuvant and/or adjuvant setting.
'''Sponsor, manager, or home institution:''' Hoffmann-La Roche
'''Intervention/Treatment:'''
Drug: Trastuzumab Emtansine;
Drug: Atezolizumab;
Other: Placebo
'''Number of patients:''' 320 participants
'''Beginning Date:''' February 5, 2021
'''Last Update:''' December 14, 2022
'''Recruitment Status:''' Recruiting
'''Cancer areas of interest:''' Metastatic Breast Cancer.
</div>
</div>


== [https://wiki.beaconcancer.org/index.php?title=Experts_(University_Hospital_for_Tumors_of_Zagreb) Experts] ==
== [[hasExperts::Experts (University Hospital for Tumours of Zagreb)|Experts]] ==
<div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide">
<div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide">
'''[https://www.kbcsm.hr/klinike/klinika-za-tumore/anesteziologija-reanimacija-i-intezivno-lijecenje/ Department of Anesthesiology, Reanimatology and Intensive Treatment]'''
'''[https://www.kbcsm.hr/klinike/klinika-za-tumore/zavod-za-kirusku-onkologiju/ Department of Head and Neck Surgery]'''
'''[https://www.kbcsm.hr/klinike/klinika-za-tumore/zavod-za-kirusku-onkologiju/odjel-za-ginekolosko-onkolosku-kirurgiju/ Department of Gynecological-Oncological Surgery]'''
'''[https://www.kbcsm.hr/klinike/klinika-za-tumore/onkoloska-patologija/ Department of Oncological Pathology and Clinical Cytology]'''
'''[https://www.kbcsm.hr/zavod-za-internisticku-onkologiju/ Department of Internal Oncology]'''
'''[https://www.kbcsm.hr/zavod-za-radioterapiju-i-onkologiju/ Department of Radiotherapy and Oncology]'''
'''[https://www.kbcsm.hr/zavod-za-onkoplastiku-i-rekonstruktivnu-kirurgiju/ Institute for Oncoplastic and Reconstructive Surgery]'''
'''[https://www.kbcsm.hr/klinike/klinika-za-tumore/zavod-za-kirusku-onkologiju/odjel-za-onkoplastiku/ Department of Oncoplasty]'''
</div>
</div>


Line 72: Line 21:
<div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide">
<div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide">


=== [[hasEvent::Events:_Courses,_events_and_symposiums_(University_Hospital_for_Tumours_of_Zagreb)|Events: Courses, events and symposiums]] ===
=== [[hasLearningResource::Resource:_Library_of_the_University_Hospital_for_Tumours_(University_Hospital_for_Tumours_of_Zagreb)|Resource: Library of the University Hospital for Tumours]] ===
=== [[hasTraining::Training:_Specialist_Training_(University_Hospital_for_Tumours_of_Zagreb)|Training: Specialist Training]] ===


</div>
</div>


== [https://wiki.beaconcancer.org/index.php?title=Novel_Therapies_and_Diagnostic_Methods_(University_Hospital_for_Tumors_of_Zagreb) Novel Therapies and Diagnostic Methods] ==
== [[hasHospitalCapacityInfo::Novel Therapies and Diagnostic Methods (University Hospital for Tumours of Zagreb)|Novel Therapies and Diagnostic Methods]] ==


== Cancer-related Patient Associations and Resources ==
<div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide">
<div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide">


=== Diagnostics ===
=== [[hasPatientResource::Resource: Patient Guides (University Hospital for Tumours of Zagreb)|Resource: Patient Guides]] ===
 
{| class="wikitable"
! Radiology !!  !!  !!
|-
| '''Type''' || '''Name''' || '''Availability''' || '''Uses per year'''
|-
| Machine || CT scanners || Yes ||
|-
| Machine || Facilities for MRI (specify the strength and field of the techniques) || Yes ||
|-
| Machine || Mammography (please specify analogic mammography or digital) || Yes ||
|-
| Machine || Ultrasound || Yes ||
|-
| Technique || CT guided biopsis || Yes ||
|-
| Technique || E/S Fine-needle biopsy || Yes ||
|-
| Technique || Vacuum-assisted breast biopsy (VABB) || Yes ||
|-
| Technique || Angiography || Yes ||
|-
! Nuclear Medicine !!  !!  !!
|-
| '''Type''' || '''Name''' || '''Availability''' || '''Uses per year'''
|-
| Machine || PET Scan || Yes ||
|-
| Machine || PET CT || Yes ||
|-
| Machine || SPECT CT || Yes ||
|-
| Technique || Bone scintigraphy || Yes ||
|-
! Pathology !!  !!  !!
|-
| '''Type''' || '''Name''' || '''Availability''' || '''Uses per year'''
|-
| Facility || Cytology laboratory || Yes ||
|-
! Pathology: Molecular Tests !!  !!  !!
|-
| '''Type''' || '''Name''' || '''Availability''' || '''Uses per year'''
|-
| Technique || KRAS || Yes ||
|-
| Technique || EGFR || Yes ||
|-
| Technique || HER2 status || Yes ||
|-
|}
 
=== Treatment ===


{| class="wikitable"
=== [[hasPatientResource::Facility: Religious services (University Hospital for Tumours of Zagreb)|Facility: Religious services]] ===
! Surgical Oncology !!  !!  !!
|-
| '''Type''' || '''Name''' || '''Availability''' || '''Uses per year'''
|-
| Specialist || Gynaecological surgery || Yes ||
|-
| Machine || Ultrasonic Scapel || Yes ||
|-
! Radiotherapy !!  !!  !!
|-
| '''Type''' || '''Name''' || '''Availability''' || '''Uses per year'''
|-
| Machine || Linear accelerators || Yes ||
|-
| Machine || Linear accelerators with IMRT/VMAT || Yes ||
|-
| Machine || Respirator || Yes ||
|-
| Machine || Gamma Knife || Yes ||
|-
! Hemato-Oncology / Bone Marrow Transplants !!  !!  !!
|-
| '''Type''' || '''Name''' || '''Availability''' || '''Uses per year'''
|-
| Facility || Transfusion Unit || Yes
|}


=== [[hasPatientResource::Facility: Exhibitions and concerts (University Hospital for Tumours of Zagreb)|Facility: Exhibitions and concerts]] ===
</div>
</div>


== Cancer-related Patient Associations and Resources ==
== [[isEHDENParticipant::EHDEN Participation (University Hospital for Tumours of Zagreb)|EHDEN Participation]] ==
<div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide">
<div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide">
</div>
</div>


== [https://wiki.beaconcancer.org/index.php?title=EHDEN_Participation_(University_Hospital_for_Tumors_of_Zagreb) EHDEN Participation] ==
__NOTOC__
<div class="mw-collapsible" data-expandtext="Show" data-collapsetext="Hide">
<span style="display:none">hasCoordinates::45.813039, 15.9433842</span>
 
<span style="display:none">hasClinicalTrial::University Hospital for Tumours of Zagreb Trials|Trials</span>
The Clinical Hospital Center “Sestre Milosrdnice” is part of the EHDEN Network of Data Partners.
<span style="display:none">hasExperts::Experts (University Hospital for Tumours of Zagreb)|Experts</span>
 
<span style="display:none">hasEvent::Events:_Courses,_events_and_symposiums_(University_Hospital_for_Tumours_of_Zagreb)|Events: Courses, events and symposiums</span>
The European Health Data and Evidence Network (EHDEN) aims to standardize European health data using OMOP-CDM to facilitate research. The project creates a federated network of data sources for easy access by researchers and policymakers. Its goal is to improve healthcare outcomes through better data quality and interoperability.
<span style="display:none">hasLearningResource::Resource:_Library_of_the_University_Hospital_for_Tumours_(University_Hospital_for_Tumours_of_Zagreb)|Resource: Library of the University Hospital for Tumours</span>
 
<span style="display:none">hasHospitalCapacityInfo::Novel Therapies and Diagnostic Methods (University Hospital for Tumours of Zagreb)|Novel Therapies and Diagnostic Methods</span>
'''Primary purpose:''' To serve as an all-encompassing platform that manages various hospital processes from admission to discharge, with ongoing updates for medical, administrative, and legislative changes.
<span style="display:none">hasPatientResource::Resource: Patient Guides (University Hospital for Tumours of Zagreb)|Resource: Patient Guides</span>
 
<span style="display:none">hasPatientResource::Facility: Religious services (University Hospital for Tumours of Zagreb)|Facility: Religious services</span>
'''Type of information:''' The database contains patient-centric data covering a wide range of hospital activities, from appointments and diagnostics to nursing and transfers, structured up to CDA level 2 details.
<span style="display:none">hasPatientResource::Facility: Exhibitions and concerts (University Hospital for Tumours of Zagreb)|Facility: Exhibitions and concerts</span>
 
<span style="display:none">isEHDENParticipant::EHDEN Participation (University Hospital for Tumours of Zagreb)|EHDEN Participation</span>
'''Data level:''' Regional level.
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span>
 
<span style="display:none">hasCancerType::C00-C97: All cancer types</span>
'''Number of records:''' 600,000 patients.
<span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span>
 
<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span>
'''Data range:''' 2010.
<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span>
 
<span style="display:none">hasCancerType::C40-C41: Bone cancers</span>
'''Open Data Access:''' Data is not publicly available. Instructions for data request [https://www.kbcsm.hr/o-bolnici/povjerenstva-kbc-sestre-milosrdnice/eticko-povjerenstvo/].
<span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span>
 
<span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span>
'''Contact information:''' Contact [https://www.kbcsm.hr/kontakt/].
<span style="display:none">hasCancerType::C50: Breast cancer</span>
 
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span>
</div>
<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span>
<span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span>
<span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span>
<span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span>
<span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span>
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span>
<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span>
<span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span>
<span style="display:none">hasCancerType::D10-D36: Benign tumour</span>
<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span>
<span style="display:none">hasCancerType::unknown</span>

Latest revision as of 16:39, 22 January 2026

forresearchers forpatients forproviders forpolicymakers croatiacountry hospital isCancerCenter Go back to Cancer Centers list.

Trials[edit | edit source]

Experts[edit | edit source]

Learning Resources[edit | edit source]

Events: Courses, events and symposiums[edit | edit source]

Resource: Library of the University Hospital for Tumours[edit | edit source]

Training: Specialist Training[edit | edit source]

Novel Therapies and Diagnostic Methods[edit | edit source]

Cancer-related Patient Associations and Resources[edit | edit source]

Resource: Patient Guides[edit | edit source]

Facility: Religious services[edit | edit source]

Facility: Exhibitions and concerts[edit | edit source]

EHDEN Participation[edit | edit source]


hasCoordinates::45.813039, 15.9433842 hasClinicalTrial::University Hospital for Tumours of Zagreb Trials|Trials hasExperts::Experts (University Hospital for Tumours of Zagreb)|Experts hasEvent::Events:_Courses,_events_and_symposiums_(University_Hospital_for_Tumours_of_Zagreb)|Events: Courses, events and symposiums hasLearningResource::Resource:_Library_of_the_University_Hospital_for_Tumours_(University_Hospital_for_Tumours_of_Zagreb)|Resource: Library of the University Hospital for Tumours hasHospitalCapacityInfo::Novel Therapies and Diagnostic Methods (University Hospital for Tumours of Zagreb)|Novel Therapies and Diagnostic Methods hasPatientResource::Resource: Patient Guides (University Hospital for Tumours of Zagreb)|Resource: Patient Guides hasPatientResource::Facility: Religious services (University Hospital for Tumours of Zagreb)|Facility: Religious services hasPatientResource::Facility: Exhibitions and concerts (University Hospital for Tumours of Zagreb)|Facility: Exhibitions and concerts isEHDENParticipant::EHDEN Participation (University Hospital for Tumours of Zagreb)|EHDEN Participation hasCancerType::C00-D48: All neoplasms hasCancerType::C00-C97: All cancer types hasCancerType::C00-C14: Mouth/throat cancers hasCancerType::C15-C26: Digestive system cancers hasCancerType::C30-C39: Lung/chest cancers hasCancerType::C40-C41: Bone cancers hasCancerType::C43-C44: Skin cancers/melanoma hasCancerType::C45-C49: Soft tissue cancer hasCancerType::C50: Breast cancer hasCancerType::C51-C58: Female genitalia cancers hasCancerType::C60-C63: Male genitalia cancer hasCancerType::C64-C68: Urinary system cancers hasCancerType::C69-C72: Eye and brain cancer hasCancerType::C73-C75: Thyroid and other gland cancers hasCancerType::C76-C80: Cancers of unknown or unspecified areas hasCancerType::C81-C96: Cancers of the blood and immune system hasCancerType::C97-C97: Cancers in multiple locations from the start hasCancerType::D00-D09: Early-stage cancers not yet spread hasCancerType::D10-D36: Benign tumour hasCancerType::D37-D48: Growths of uncertain nature hasCancerType::unknown

Retrieved from "https://wiki.beaconcancer.org/index.php?title=University_Hospital_for_Tumours_of_Zagreb&oldid=36205"
Powered by MediaWiki
Powered by Semantic MediaWiki